About this episode

This episode features an interview with Dr. Edward Cliff discussing his research on the global access to CAR T-cell therapies.

In this week's episode, Blood podcast editor Laurie Sehn interviews Drs. Edward Cliff on his latest research published in volume 147 issue 14 of Blood . Dr. Cliff discusses " Global access to commercial CAR T-cell therapies: a cross-sectional study of health technology assessment across the G20 countries " which maps the mismatch between innovation and implementation across high-income and selected-upper-middle-income countries for US Food and Drug Administration–approved products and indications.

People in this episode

Host: Laurie Sehn

Guest: Dr. Edward Cliff

Topics covered

• CAR T-cell therapies
• health technology assessment
• global access
• innovation
• implementation
• high-income countries
• upper-middle-income countries

Keywords

• CAR T-cell therapies
• health technology assessment
• G20
• FDA
• global access
• innovation
• implementation

Mentioned in this episode

Organizations: Blood, US Food and Drug Administration

Places: G20 countries

More episodes of Blood Podcast

• Pathophysiology of ANKRD26-related thrombocytopenia and B-ALL recurrence after blinatumomab · April 23, 2026 · 19 min
• Consequences of p53 loss and Gastrin for aGVHD of the Stomach · April 9, 2026 · 20 min
• Review Series on Myeloproliferative Neoplasms · April 2, 2026 · 26 min
• CH in children with SCD and Asciminib for CML in the ASC4FIRST trial · March 26, 2026 · 14 min
• Emerging Mechanisms: Neutrophils and Immune thrombocytopenia from ICI · March 19, 2026 · 20 min
• Hepcidin-DMT1 interaction and GPRC5D-targeting bispecific antibody for MM · March 12, 2026 · 16 min

Explore listener stats, chart rankings, contacts and more on the Blood Podcast podcast page.